Stock Trend Analysis Report
Prepared for you on Friday, December 8, 2023.
Talis Biomedical Corporation - common stock (NASDAQ:TLIS)
Long-Term Uptrend (+90) - TLIS is in a strong uptrend that is likely to continue. While TLIS is showing intraday weakness, it remains in the confines of a bullish trend. Traders should use caution and utilize a stop order.
Is it time to buy, sell, or avoid TLIS?
MarketClub looks at technical strength and momentum to determine if the timing is right for TLIS.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
MarketClub’s Trade Triangles for TLIS
The long-term trend has been UP since Dec 1st, 2023 at 7.750
The intermediate-term trend has been UP since Nov 3rd, 2023 at 5.800
The short-term trend has been UP since Nov 20th, 2023 at 7.318
Smart Scan Analysis for TLIS
Based on our trend formula, TLIS is rated as a +90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
|52wk High||9.75||52wk High Date||2023-01-23|
|52wk Low||4.35||52wk Low Date||2023-10-31|
|Average Volume||31,658||Shares Outstanding||1,821|